Baudax Bio Ownership 2024 | Who Owns Baudax Bio Now?
Institutional Ownership
0.01%
Insider Ownership
0.02%
Retail Ownership
99.97%
Institutional Holders
1.00
Baudax Bio Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9.89% | - | 32,812 | 32,812 | 100.00% | 55,780,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 7.51% | - | 24,900 | 24,900 | 100.00% | 42,330,000 | Mar 31, 2023 |
STATE STREET CORP | 3.50% | - | 11,602 | -7,200 | -38.29% | 19,723,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.47% | 0.00% | 1,548 | 1,247 | 414.29% | 3,000 | Mar 31, 2023 |
JPMORGAN CHASE & CO | 0.46% | - | 1,511 | 1,511 | 100.00% | 3,000,000 | Mar 31, 2023 |
FMR LLC | 0.32% | - | 1,056 | 1,056 | 100.00% | 1,795,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.24% | - | 797 | - | - | 1,355,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 22 | 22 | 100.00% | 35,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 4 | - | - | 7,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 3 | - | - | 5,000 | Mar 31, 2023 |
SITTNER & NELSON, LLC | 0.00% | - | 1 | - | - | 2,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 1 | -1 | -50.00% | 2,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -3,011 | -100.00% | - | Mar 31, 2023 |
EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -71 | -100.00% | - | Mar 31, 2023 |
Baudax Bio's largest institutional shareholder is SUSQUEHANNA INTERNATIONAL GROUP, LLP, holding 9.89% of the company's total share outstanding, currently valued at $55.78M. The top 10 institutional shareholders own together 22.39% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
TOWER RESEARCH CAPITAL LLC (TRC) | 0.47% | 0.00% | 1,548 | 1,247 | 414.29% | 3,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9.89% | - | 32,812 | 32,812 | 100.00% | 55,780,000 | Mar 31, 2023 |
SITTNER & NELSON, LLC | 0.00% | - | 1 | - | - | 2,000 | Mar 31, 2023 |
STATE STREET CORP | 3.50% | - | 11,602 | -7,200 | -38.29% | 19,723,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 7.51% | - | 24,900 | 24,900 | 100.00% | 42,330,000 | Mar 31, 2023 |
JPMORGAN CHASE & CO | 0.46% | - | 1,511 | 1,511 | 100.00% | 3,000,000 | Mar 31, 2023 |
FMR LLC | 0.32% | - | 1,056 | 1,056 | 100.00% | 1,795,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 22 | 22 | 100.00% | 35,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.24% | - | 797 | - | - | 1,355,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 4 | - | - | 7,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 3 | - | - | 5,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 1 | -1 | -50.00% | 2,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -3,011 | -100.00% | - | Mar 31, 2023 |
EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -71 | -100.00% | - | Mar 31, 2023 |
The largest Baudax Bio shareholder by % of total assets is TOWER RESEARCH CAPITAL LLC (TRC). The company owns 1.55K shares of Baudax Bio (BXRX), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9.89% | - | 32,812 | 32,812 | 100.00% | 55,780,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 7.51% | - | 24,900 | 24,900 | 100.00% | 42,330,000 | Mar 31, 2023 |
JPMORGAN CHASE & CO | 0.46% | - | 1,511 | 1,511 | 100.00% | 3,000,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.47% | 0.00% | 1,548 | 1,247 | 414.29% | 3,000 | Mar 31, 2023 |
FMR LLC | 0.32% | - | 1,056 | 1,056 | 100.00% | 1,795,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 22 | 22 | 100.00% | 35,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 3 | - | - | 5,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 4 | - | - | 7,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.24% | - | 797 | - | - | 1,355,000 | Mar 31, 2023 |
SITTNER & NELSON, LLC | 0.00% | - | 1 | - | - | 2,000 | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 1 | -1 | -50.00% | 2,000 | Mar 31, 2023 |
EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -71 | -100.00% | - | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -3,011 | -100.00% | - | Mar 31, 2023 |
STATE STREET CORP | 3.50% | - | 11,602 | -7,200 | -38.29% | 19,723,000 | Mar 31, 2023 |
As of Mar 31 2023, Baudax Bio's largest institutional buyer is SUSQUEHANNA INTERNATIONAL GROUP, LLP. The company purchased 32.81K stocks of BXRX, valued at $55.78M.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
STATE STREET CORP | 3.50% | - | 11,602 | -7,200 | -38.29% | 19,723,000 | Mar 31, 2023 |
UBS GROUP AG | - | - | - | -3,011 | -100.00% | - | Mar 31, 2023 |
EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -71 | -100.00% | - | Mar 31, 2023 |
MORGAN STANLEY | 0.00% | - | 1 | -1 | -50.00% | 2,000 | Mar 31, 2023 |
SITTNER & NELSON, LLC | 0.00% | - | 1 | - | - | 2,000 | Mar 31, 2023 |
BLACKROCK INC. | 0.24% | - | 797 | - | - | 1,355,000 | Mar 31, 2023 |
GROUP ONE TRADING, L.P. | 0.00% | - | 4 | - | - | 7,000 | Mar 31, 2023 |
WELLS FARGO & COMPANY/MN | 0.00% | - | 3 | - | - | 5,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 22 | 22 | 100.00% | 35,000 | Mar 31, 2023 |
FMR LLC | 0.32% | - | 1,056 | 1,056 | 100.00% | 1,795,000 | Mar 31, 2023 |
TOWER RESEARCH CAPITAL LLC (TRC) | 0.47% | 0.00% | 1,548 | 1,247 | 414.29% | 3,000 | Mar 31, 2023 |
JPMORGAN CHASE & CO | 0.46% | - | 1,511 | 1,511 | 100.00% | 3,000,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 7.51% | - | 24,900 | 24,900 | 100.00% | 42,330,000 | Mar 31, 2023 |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9.89% | - | 32,812 | 32,812 | 100.00% | 55,780,000 | Mar 31, 2023 |
As of Mar 31 2023, Baudax Bio's biggest institutional seller is STATE STREET CORP. The company sold -7.20K shares of BXRX, valued at $19.72M.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 9.89% | - | 32,812 | 32,812 | 100.00% | 55,780,000 | Mar 31, 2023 |
VANGUARD GROUP INC | 7.51% | - | 24,900 | 24,900 | 100.00% | 42,330,000 | Mar 31, 2023 |
JPMORGAN CHASE & CO | 0.46% | - | 1,511 | 1,511 | 100.00% | 3,000,000 | Mar 31, 2023 |
FMR LLC | 0.32% | - | 1,056 | 1,056 | 100.00% | 1,795,000 | Mar 31, 2023 |
ADVISOR GROUP HOLDINGS, INC. | 0.01% | - | 22 | 22 | 100.00% | 35,000 | Mar 31, 2023 |
Baudax Bio's largest new institutional shareholder by number of shares is SUSQUEHANNA INTERNATIONAL GROUP, LLP, purchased 32.81K shares, valued at $55.78M, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
UBS GROUP AG | - | - | - | -3,011 | -100.00% | - | Mar 31, 2023 |
EDMOND DE ROTHSCHILD HOLDING S.A. | - | - | - | -71 | -100.00% | - | Mar 31, 2023 |
Baudax Bio's largest sold out institutional shareholder by shares sold is UBS GROUP AG, sold -3.01K shares, valued at -, as of undefined.
Baudax Bio Mutual Fund Holders
Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
---|---|---|---|---|---|
OBERWEIS FUNDS | 0.13% | 133,160 | - | - | Mar 31, 2024 |
AMG FUNDS III | 0.01% | 33,658 | - | - | Mar 28, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 64,352 | - | - | Feb 29, 2024 |
Voya VARIABLE PORTFOLIOS INC | 0.00% | 6,248 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 58,320 | - | - | Mar 31, 2024 |
Meeder Funds | 0.00% | 647 | - | - | Mar 31, 2024 |
VANGUARD INDEX FUNDS | 0.00% | 48,300 | - | - | Mar 31, 2024 |
PRUDENTIAL INVESTMENT PORTFOLIOS, INC. | 0.00% | 1,040 | - | - | Mar 28, 2024 |
NORTHERN FUNDS | 0.00% | 5,890 | - | - | Mar 28, 2024 |
ALLSPRING MASTER TRUST | 0.00% | 1,009 | - | - | Feb 29, 2024 |
FIDELITY CONCORD STREET TRUST | 0.00% | 1,552 | - | - | Feb 29, 2024 |
PENN SERIES FUNDS INC | 0.00% | 200 | - | - | Mar 28, 2024 |
JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 4,631 | - | - | Mar 31, 2024 |
MASSMUTUAL SELECT FUNDS | 0.00% | 1,155 | - | - | Dec 31, 2023 |
T. Rowe Price Index Trust, Inc. | 0.00% | 23 | - | - | Feb 29, 2024 |
Blackstone Alternative Investment Funds | 0.00% | 43 | - | - | Mar 31, 2023 |
EQ ADVISORS TRUST | 0.00% | 417 | - | - | Mar 31, 2024 |
Baudax Bio's largest mutual fund holder by % of total assets is "OBERWEIS FUNDS", owning 133.16K shares, compromising 0.13% of its total assets.
Baudax Bio Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 22 | 1 | -93.33% |
30 Sep, 22 | 15 | - |
30 Jun, 22 | 15 | -6.25% |
31 Mar, 22 | 16 | - |
As of 31 Dec 22, 1 institutions are holding Baudax Bio's shares, representing a decrease of -93.33% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 22 | 71 | -100.00% |
30 Sep, 22 | 1,432,997 | 12.24% |
30 Jun, 22 | 1,276,758 | 2.68% |
31 Mar, 22 | 1,243,391 | - |
Baudax Bio (BXRX) has 71.00 shares outstanding as of 31 Dec 22, down -100.00% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 22 | 0.01% | 0.04% |
30 Sep, 22 | 4.78% | 26.37% |
30 Jun, 22 | 4.26% | 24.78% |
31 Mar, 22 | 4.14% | - |
As of 31 Dec 22, Baudax Bio is held by 0.01% institutional shareholders, representing a 0.04% growth compared to 30 Sep 22.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 22 | - | -100.00% |
30 Sep, 22 | 10 | 25.00% |
30 Jun, 22 | 8 | -50.00% |
31 Mar, 22 | 16 | - |
- institutional shareholders have increased their position in BXRX stock as of 31 Dec 22 compared to 10 in the previous quarter (a -100.00% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 22 | 1 | -66.67% |
30 Sep, 22 | 3 | - |
30 Jun, 22 | 3 | - |
31 Mar, 22 | - | - |
1 institutional shareholders have reduced their position in BXRX stock as of 31 Dec 22 compared to 3 in the previous quarter (a -66.67% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 22 | 1 | -93.33% | 71 | -100.00% | 0.01% | 0.04% | - | -100.00% | 1 | -66.67% |
30 Sep, 22 | 15 | - | 1,432,997 | 12.24% | 4.78% | 26.37% | 10 | 25.00% | 3 | - |
30 Jun, 22 | 15 | -6.25% | 1,276,758 | 2.68% | 4.26% | 24.78% | 8 | -50.00% | 3 | - |
31 Mar, 22 | 16 | - | 1,243,391 | - | 4.14% | - | 16 | - | - | - |
Baudax Bio Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Baudax Bio's stock was made by Kim Yong Chan on Jul 13 2023, selling - shares at - per share (valued at -). The last insider buy of BXRX was made by HENWOOD GERALDINE on Dec 19 2022, buying 1,200 shares at $2.55 per share (worth $3.06K).
Baudax Bio Insider Ownership Trends
All Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | - | - | - |
Q3 2023 | - | 2 | - |
Q4 2022 | 1 | - | - |
Q2 2022 | 7 | 6 | 116.67% |
Q4 2021 | 1 | 2 | 50.00% |
Q3 2021 | 3 | - | - |
Q2 2021 | 17 | - | - |
Q1 2021 | 10 | 1 | 1000.00% |
Q4 2020 | 1 | 4 | 25.00% |
Q3 2020 | 2 | - | - |
Q2 2020 | 8 | - | - |
Q1 2020 | 6 | 2 | 300.00% |
Q4 2019 | 11 | 2 | 550.00% |
0 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Baudax Bio's insiders, as of Q4 2023.
Open Market Insider Trades Trend
Date | Buy | Sell | Buy/Sell Ratio |
---|---|---|---|
Q4 2023 | - | - | - |
Q3 2023 | - | - | - |
Q4 2022 | 1 | - | - |
Q2 2022 | - | - | - |
Q4 2021 | - | - | - |
Q3 2021 | 3 | - | - |
Q2 2021 | 5 | - | - |
Q1 2021 | 1 | - | - |
Q4 2020 | 1 | - | - |
Q3 2020 | - | - | - |
Q2 2020 | - | - | - |
Q1 2020 | 4 | - | - |
Q4 2019 | - | - | - |
As of Q4 2023, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Baudax Bio's stocks.
Baudax Bio Peer Ownership
Ticker | Company |
---|---|
BDRX | Biodexa Pharmaceuticals Plc |
CFRX | ContraFect Corporation |
CNSP | CNS Pharmaceuticals, Inc. |
ENSC | Ensysce Biosciences, Inc. |
NEXI | NexImmune, Inc. |
QNRX | Quoin Pharmaceuticals, Ltd. |
YS | LakeShore Biopharma Co., Ltd |
HILS | Tharimmune, Inc. |
DRMA | Dermata Therapeutics, Inc. |
VRAX | Virax Biolabs Group Limited |
ALLR | Allarity Therapeutics, Inc. |
CYTO | Altamira Therapeutics Ltd. |
NRBO | NeuroBo Pharmaceuticals, Inc. |
WINT | Windtree Therapeutics, Inc. |
PALI | Palisade Bio, Inc. |
BXRX Ownership FAQ
Who Owns Baudax Bio?
Baudax Bio is owned by institutional shareholders (0.01%), insiders (0.02%), and public (99.97%). The largest institutional shareholder of Baudax Bio is SUSQUEHANNA INTERNATIONAL GROUP, LLP (9.89% of total shares) and the top mutual fund owner is OBERWEIS FUNDS (0.13% of total shares).
Who are the major institutional shareholders of Baudax Bio?
Baudax Bio's major institutional shareholders are SUSQUEHANNA INTERNATIONAL GROUP, LLP, VANGUARD GROUP INC, STATE STREET CORP, TOWER RESEARCH CAPITAL LLC (TRC), and JPMORGAN CHASE & CO. The top five shareholders own together 21.82% of the company's share outstanding.
How many Baudax Bio shareholders are there?
As of Dec 2022, there are 1 institutional shareholders of Baudax Bio.
What percentage of Baudax Bio is owned by SUSQUEHANNA INTERNATIONAL GROUP, LLP?
SUSQUEHANNA INTERNATIONAL GROUP, LLP owns 32.81K shares of Baudax Bio, representing 9.89% of the company's total shares outstanding, valued at $55.78M (as of Mar 2023).
What percentage of Baudax Bio is owned by VANGUARD GROUP INC?
As of Mar 2023, VANGUARD GROUP INC holds 24.9K shares of Baudax Bio (BXRX), compromising 7.51% of the company, valued at $42.33M.
What percentage of Baudax Bio is owned by STATE STREET CORP?
STATE STREET CORP is the third largest holder of Baudax Bio. The company owns 11.6K of the company's shares outstanding (worth $19.72M).